Cargando…
The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
SIMPLE SUMMARY: Protein lysine acetylation is, with phosphorylation, the most common regulatory post-translational modification of proteins. Histone deacetylases (HDAC) catalyze the removal of acetyl groups from histone and non-histone proteins, participating in the modulation of several pathways. H...
Autores principales: | Cellupica, Edoardo, Caprini, Gianluca, Fossati, Gianluca, Mirdita, Doris, Cordella, Paola, Marchini, Mattia, Rocchio, Ilaria, Sandrone, Giovanni, Stevenazzi, Andrea, Vergani, Barbara, Steinkühler, Christian, Vanoni, Maria Antonietta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452033/ https://www.ncbi.nlm.nih.gov/pubmed/37626935 http://dx.doi.org/10.3390/biology12081049 |
Ejemplares similares
-
Difluoromethyl-1,3,4-oxadiazoles are slow-binding substrate analog inhibitors of histone deacetylase 6 with unprecedented isotype selectivity
por: Cellupica, Edoardo, et al.
Publicado: (2022) -
HDAC Inhibition as Potential Therapeutic Strategy to Restore the Deregulated Immune Response in Severe COVID-19
por: Ripamonti, Chiara, et al.
Publicado: (2022) -
Identification of a Novel SSTR3 Full Agonist for the Treatment of Nonfunctioning Pituitary Adenomas
por: Modena, Daniela, et al.
Publicado: (2023) -
The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene
por: Licandro, Simonetta Andrea, et al.
Publicado: (2021) -
Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2014)